SCHEMBL665344

SCHEMBL665344

Fc1cc(C(F)(F)F)cnc1Br

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
TRPA1 O75762 2/20 0.36
POLB P06746 2/20 0.36
KDM4E B2RXH2 2/20 0.36
PLAU P00749 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
AGBL2 Q5U5Z8 1/20 0.36
GAA P10253 3/20 0.36
USP2 O75604 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
HTT P42858 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
PDE2A O00408 1/20 0.33
ALOX5AP P20292 1/20 0.33
FEN1 P39748 1/20 0.33
RXRA P19793 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2B Q13224 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29438077 1.00 ALDH1A1 (0.38) ALDH1A1TRPA1POLBKDM4EPLAU
SCHEMBL9264505 0.81
SCHEMBL10354420 0.80 ALDH1A1 (0.39) ALDH1A1POLBKDM4EPLAUSMN1; SMN2
SCHEMBL31547985 0.78 AGBL2 (0.47) ALDH1A1POLBKDM4EPLAUSMN1; SMN2
SCHEMBL31002183 0.78 CYP11B2 (0.36) RXRAGRIN1GRIN2B
SCHEMBL609041 0.77 ALDH1A1 (0.40) ALDH1A1TRPA1POLBKDM4EPLAU
SCHEMBL23746896 0.77 ALDH1A1 (0.45) ALDH1A1POLBKDM4EPLAUSMN1; SMN2
SCHEMBL18299209 0.77 ALDH1A1 (0.42) ALDH1A1POLBKDM4EPLAUSMN1; SMN2
SCHEMBL2596379 0.77 ALDH1A1 (0.53) ALDH1A1POLBKDM4EPLAUSMN1; SMN2
SCHEMBL30060619 0.77 ALDH1A1 (0.45) ALDH1A1POLBKDM4EPLAUSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568960-B1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2026-04-29 EP disclosed
US-20250236614-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2025-07-24 US disclosed
US-12351584-B2 Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2025-07-08 US disclosed
US-20250154107-A1 3,4-Dihydroisoquinolin-1(2H)-Ones Derivatives as STING Antagonists and the Use Thereof BEIGENE SWITZERLAND GMBH (CH) 2025-05-15 US disclosed
US-20250034170-A1 SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF VANQUA BIO, INC. (US) 2025-01-30 US disclosed
US-20240398781-A1 SPIROCYCLIC CYCLIC MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYELINATION CONVELO THERAPEUTICS, INC. 2024-12-05 US disclosed
EP-4436975-A1 SPIROCYCLIC CYCLIC MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYELINATION Genentech, Inc. (US) 2024-10-02 EP disclosed
EP-4415706-A1 SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF Vanqua Bio, Inc. (US) 2024-08-21 EP disclosed
WO-2024033458-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2024-02-15 WO disclosed
US-20230303573-A1 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives Grünenthal GmbH (DE) 2023-09-28 US disclosed
EP-0097460-B1 PYRIDYL(OXY/THIO)PHENOXY COMPOUNDS, HERBICIDAL COMPOSITIONS AND METHODS THE DOW CHEMICAL COMPANY (US) 1988-04-06 EP disclosed
US-4678509-A GRASSY WEEDS THE DOW CHEMICAL COMPANY (US) 1987-07-07 US disclosed
US-4625035-A 2,3-difluoro-5-(trifluoromethyl)pyridine THE DOW CHEMICAL COMPANY (US) 1986-11-25 US disclosed
US-4565568-A Pyridyl(oxy/thio)phenoxy compounds, herbicidal compositions and methods THE DOW CHEMICAL COMPANY (US) 1986-01-21 US disclosed
US-4480102-A 2,3-Difluoro-5-(trifluoromethyl)pyridine and methods of making and using the same THE DOW CHEMICAL COMPANY (US) 1984-10-30 US disclosed
EP-0034917-B1 2-SUBSTITUTED-5-TRIFLUOROMETHYLPYRIDINES AND A PROCESS FOR PRODUCING THE SAME ISHIHARA SANGYO KAISHA LTD. (JP) 1984-08-08 EP disclosed
EP-0104715-A2 2,3-Difluoro-5-(trifluoromethyl)pyridine and method of making and using the same THE DOW CHEMICAL COMPANY (US) 1984-04-04 EP disclosed
EP-0097460-A1 Pyridyl(oxy/thio)phenoxy compounds, herbicidal compositions and methods THE DOW CHEMICAL COMPANY (US) 1984-01-04 EP disclosed
US-4367336-A 2-Substituted-5-trifluoromethylpyridines and process for producing the same ISHIHARA SANGYO KAISHA, LTD. (JP) 1983-01-04 US disclosed
EP-0034917-A1 2-Substituted-5-trifluoromethylpyridines and a process for producing the same ISHIHARA SANGYO KAISHA LTD. (JP) 1981-09-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250034170-A1 SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF GBA1, GAA, GBA2 ALDH1A1 1971/4885TRPA1 4016/4885POLB 1535/4885
US-20230303573-A1 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives OPRK1, OPRD1, OPRL1 ALDH1A1 337/4885TRPA1 38/4885POLB 2650/4885
US-20250236614-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES GRIN2C, CNR1, CNR2 ALDH1A1 871/4885TRPA1 469/4885POLB 3866/4885
US-20240398781-A1 SPIROCYCLIC CYCLIC MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYELINATION MAG, PMP22, NR1H2 ALDH1A1 2545/4885TRPA1 4527/4885POLB 2847/4885
US-12351584-B2 Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide CNP, PDE3A, PDE5A ALDH1A1 344/4885TRPA1 2729/4885POLB 2037/4885
US-20250154107-A1 3,4-Dihydroisoquinolin-1(2H)-Ones Derivatives as STING Antagonists and the Use Thereof STING1, IRF3, MAVS ALDH1A1 4770/4885TRPA1 735/4885POLB 703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.